Central nervous system disturbances following clarithromycin ingestion.
Geiderman
J M
JM
Ruth and Harry Roman Emergency Department, Burns and Allen Research Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. geiderman@cshs.org
D000284:Administration, Oral; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000139:chemically induced*; D002675:Child, Preschool; D017291:Clarithromycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005059:Euphoria / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011595:Psychomotor Agitation; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D013610:Tachycardia / Q000139:chemically induced
D000900:Anti-Bacterial Agents; D017291:Clarithromycin